Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 112 results:
Συντάκτης [ Τίτλος![(Desc)](https://www.med.auth.gr/sites/all/modules/biblio/misc/arrow-desc.png)
Φίλτρα: Συντάκτης is Anagnostis, Panagiotis [Clear All Filters]
Health benefits of the Mediterranean Diet: an update of research over the last 5 years..
Angiology. 66(4), 304-18.
(2015). "Holidays" for osteoporosis drugs: A case-based approach..
Case Rep Womens Health. 23, e00127.
(2019). Hypoglycemia in a patient with advanced Sezary syndrome..
Leuk Lymphoma. 50(2), 284-6.
(2009). The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study..
Curr Vasc Pharmacol. 11(5), 779-84.
(2013). Impact of statins on glucose metabolism--a matter of debate..
Am J Cardiol. 107(12), 1866.
(2011). Letter to the Editor: "Androgens, Irregular Menses, and Risk of Diabetes and Coronary Artery Calcification in the Diabetes Prevention Program"..
J Clin Endocrinol Metab. 103(5), 2066-2067.
(2018). Letter to the Editor: "Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease"..
J Clin Endocrinol Metab. 104(8), 3124.
(2019). Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline"..
J Clin Endocrinol Metab. 105(1),
(2020). Lipoprotein(a) in postmenopausal women: assessment of cardiovascular risk and therapeutic options..
Int J Clin Pract. 70(12), 967-977.
(2016).
(2012). Management of Acute Hip Fracture..
N Engl J Med. 378(10), 971-2.
(2018). Management of dyslipidaemias in the elderly population-A narrative review..
Maturitas. 124, 93-99.
(2019). Maternal vitamin D status in pregnancy: a critical appraisal of current analytical data on maternal and neonatal outcomes..
Hormones (Athens). 14(2), 224-31.
(2015). Menopausal Hormone Therapy and Cardiovascular Risk: Where are we Now?.
Curr Vasc Pharmacol. 17(6), 564-572.
(2019). Menopause and its Cardiometabolic Consequences: Current Perspectives..
Curr Vasc Pharmacol. 17(6), 543-545.
(2019). Menopause symptom management in women with dyslipidemias: An EMAS clinical guide..
Maturitas. 135, 82-88.
(2020). Menopause-associated risk of cardiovascular disease..
Endocr Connect. 11(4),
(2022). Monitoring the efficacy of once-weekly teriparatide. Are bone turnover markers useful in predicting fracture risk?.
Curr Med Res Opin. 30(6), 1177-8.
(2014). Multifactorial intervention for the prevention of vascular complications of type 2 diabetes..
Hellenic J Cardiol. 50(6), 445-8.
(2009). New therapeutic targets for osteoporosis..
Maturitas. 120, 1-6.
(2019).
(2019). Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block..
Curr Vasc Pharmacol.
(2019). Non-coronary atherosclerotic cardiovascular disease in patients with familial hypercholesterolaemia..
Curr Med Res Opin. 1-10.
(2020). Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid..
Endokrynol Pol. 63(4), 312-5.
(2012). Obesity, Metabolic Syndrome and the Risk of Microvascular Complications in Patients with Diabetes mellitus..
Curr Pharm Des. 25(18), 2051-2059.
(2019).